Submitted by Anonymous (not verified) on 21 November 2023 - 14:08
Human medicines European public assessment report (EPAR): Prometax, rivastigmine, Alzheimer Disease;Parkinson Disease;Dementia, Date of authorisation: 03/12/1998, Revision: 46, Status: Authorised
Source: